fusariosis

fusariosis

(fū-sar-ē-ō'sis),
Fungal infection owing to the genus Fusarium.

fusariosis

(fū-zār″ē-ō′sĭs) [Fusarium + ″]
Infection or intoxication by species of the genus Fusarium. It typically affects immunocompromised patients.
References in periodicals archive ?
1 must meet the following standard: PN-69 / R-74016 (impurities no more than a total of 12%, 4% moisture useless no more than 15%, no grain infected with fusariosis, moldy grains less than 1%, ergot less than 0.
Similarly, fusariosis usually occurs in immunocompromised hosts; endophthalmitis has been reported but usually as a sequela of Fusarium keratitis (10,34) and not de novo, as in this outbreak.
Ecthyma gangrenosum-like lesions due to disseminated fusariosis might be easily misdiagnosed as lesions associated with Pseudomonas unless tissue cultures and histopathological examinations are performed.
Indeed, these by-products input a dangerous fungus Fusarium oxysporum fsp albedinis (Fusarium), causal agent of the vascular fusariosis (Bayoud), which is a pathogenic agent causes drastic reduction in cultivation and expansion of date palm in Morocco and Algeria [22,14].
Vorikonazol ozellikle Aspergillus, Scedosporiosis, Fusariosis, Kandidiasis tedavilerinde ve diger duyarli fungal enfeksiyon tedavisinde verilebilir.
Posaconazole has shown promise in the treatment of invasive fusariosis, Scedosporium apiospermum infections, disseminated phaeohyphomycosis due to Exophiala spinifera, and refractory coccidioidomycosis infections (36-40).
To the best of our knowledge, this is the first reported case of isolated pulmonary fusariosis in an apparently immunocompetent person.
NOXAFIL is indicated for use in treating invasive aspergillosis, fusariosis, chromoblastomycosis, mycetoma and coccidioidomycosis in adult patients with refractory disease or who are intolerant of certain commonly used antifungal agents.
Treatment was effective in 44% of patients with aspergillosis, 55% with candidiasis, 39% with cryptococcosis, 45% with fusariosis, 90% with penicilliosis, and 30% with scedosporiosis.
Distinguish the most common underlying diagnosis of patients with invasive fusariosis in the current study
NOXAFIL, upon approval, would provide a new therapeutic option for serious infections caused by aspergillosis, fusariosis, chromoblastomycosis, mycetoma, and coccidioidomycosis.
Very encouraging" data have been posted regarding voriconazole for a variety of other fungal infections, including disseminated candidiasis and candidemia refractory to standard first-generation triazole therapy, esophageal candidiasis, fusariosis, and blastomycosis.